We believe this site might serve you best:

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Beta-Glo® Assay System Technical Manual

Instructions for Use of Product(s)
E4720, E4740, E4780
Literature # TM239

The Beta-Glo® Assay System is a homogeneous method used to quantitate β-galactosidase expression in mammalian cells. High-throughput quantitation of β-galactosidase expression in mammalian cells is commonly performed by batch processing of 96- and 384-well plates. The homogeneous assay procedure involves the addition of a single reagent directly to cells cultured in serum-supplemented medium. Throughput rates of several thousand samples per hour may be achieved with high reproducibility under standard laboratory conditions. The luminescent signal generated by the Beta-Glo® Reagent may be measured after 30 minutes for more than 4 hours in common culture medium. The extended luminescence eliminates the need for reagent injectors and provides flexibility for continuous or batch processing of multiple plates.
The Beta-Glo® Assay System consists of two components that are combined to form Beta-Glo® Reagent. This single reagent provides a coupled enzyme reaction system utilizing a luciferin-galactoside substrate(6-O-β-galactopyranosyl-luciferin). This substrate is cleaved by β-galactosidase to form luciferin and galactose. The luciferin is then utilized in a firefly luciferase reaction to generate light. Since a single reagent lyses cells and contains all of the components required to generate a luminescent signal that is proportional to the amount of β-galactosidase, many plates can be processed quickly and efficiently.

Printed in USA. Revised 9/11.

Choose your country

Americas

Brazil
Canada
United States

Pacific Asia

Australia
India
Japan
Korea, Republic of
Singapore

Europe

Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Italy
Luxembourg
Netherlands
Norway
Poland
Spain
Sweden
Switzerland
United Kingdom